Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

S&P Pharmaceuticals SPDR (XPH)

S&P Pharmaceuticals SPDR (XPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
Trade XPH with:
  • Price/Earnings ttm 9.04
  • Annual Dividend & Yield 0.55 (1.34%)
  • Most Recent Dividend 0.181 on 03/21/22
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 33.39% ( -2.52%)
  • Historical Volatility 30.06%
  • IV Percentile 93%
  • IV Rank 76.04%
  • IV High 38.84% on 05/09/22
  • IV Low 16.07% on 06/18/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 3.22
  • Today's Open Interest 274
  • Open Int (30-Day) 288

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.94 +9.52%
on 05/12/22
42.32 -1.82%
on 04/29/22
+0.03 (+0.07%)
since 04/26/22
3-Month
37.94 +9.52%
on 05/12/22
46.61 -10.86%
on 04/07/22
-2.27 (-5.18%)
since 02/25/22
52-Week
37.94 +9.52%
on 05/12/22
53.82 -22.80%
on 07/29/21
-8.66 (-17.25%)
since 05/26/21

Most Recent Stories

More News
Pharma ETFs in Focus Post Q1 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

PJP : 75.29 (+0.32%)
IHE : 194.64 (+0.89%)
XPH : 41.55 (+1.14%)
PPH : 79.70 (+0.64%)
FTXH : 26.65 (-0.04%)
Implied XPH Analyst Target Price: $62

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

Sector ETF report for XPH

XPH : 41.55 (+1.14%)
BMY : 77.59 (+0.45%)
JAZZ : 152.46 (+3.01%)
IHE : 194.64 (+0.89%)
PPH : 79.70 (+0.64%)
OGN : 38.56 (+1.21%)
Analysts Anticipate 41% Gains Ahead For XPH

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)
Analysts Expect 46% Upside For XPH

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

Smart Beta ETF report for XPH

XPH : 41.55 (+1.14%)
MRK : 92.31 (-1.54%)
PRGO : 40.16 (+2.32%)
IHE : 194.64 (+0.89%)
PPH : 79.70 (+0.64%)
OGN : 38.56 (+1.21%)
Peek Under The Hood: XPH Has 46% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)
Analysts Predict 58% Gains Ahead For XPH

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)
Solid Q4 Earnings Fail to Impress Pharma ETFs

Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.

PJP : 75.29 (+0.32%)
IHE : 194.64 (+0.89%)
XPH : 41.55 (+1.14%)
PPH : 79.70 (+0.64%)
FTXH : 26.65 (-0.04%)
XPH's Holdings Imply 51% Gain Potential

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...

XPH : 41.55 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 42.06
2nd Resistance Point 41.93
1st Resistance Point 41.74
Last Price 41.55
1st Support Level 41.42
2nd Support Level 41.29
3rd Support Level 41.10

See More

52-Week High 53.82
Fibonacci 61.8% 47.75
Fibonacci 50% 45.88
Fibonacci 38.2% 44.01
Last Price 41.55
52-Week Low 37.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar